glp-1 agonists addiction Ozempic for addiction? 🤯 New BMJ data from 600K+ patients shows GLP-1s may reduce overdose risk by 39% and substance-related death by 50%. The brain’s reward system just got a whole lot more Purchase Type:MB-1 | 6 Month Delivery sold_in_US Glucose-dependent insulinotropic polypeptide receptor

glp-1 agonists addiction Ozempic for addiction? 🤯 New BMJ data from 600K+ patients shows GLP-1s may reduce overdose risk by 39% and substance-related death by 50%. The brain’s reward system just got a whole lot more Purchase Type:MB-1 | 6 Month Delivery sold_in_US Glucose-dependent insulinotropic polypeptide receptor

Glucose-dependent insulinotropic polypeptide receptor signaling in oligodendrocytes increases the weight-loss action of GLP-1R agonism: Cell Metabolism

Treatment continuation depends on achieving specified weight loss targets as defined in the product-specific NICE guidance and SmPCs

sold_in_US

Purchase Type:MB-1 | 6 Month Delivery

None of the patients from the case series was rechallenged with GLP-1 RAs due to safety concerns